Been looking into MRK pretty hard and i’m not seeing the counterargument to being well- and heavily-positioned in them by mid-Q1. Great financials, great pipeline, solid mgmt, and heavily undervalued by seemingly temporary issues shared by all non-vaccine pharma right now.
Seems to good to be true though, anyone have a counterargument against Merck? What am i missing? Not a pump post, a genuine worry that I have a blind spot in my analysis.
Submitted December 16, 2020 at 10:26PM by No_Werewolf_1214 https://ift.tt/3akb4E8
